Center for Global Health Policy’s “Science Speaks”: Where harm reduction policies went up, hepatitis C incidence went down, study finds
Antigone Barton, senior editor and writer of “Science Speaks,” discusses findings from research published in Clinical Infectious Diseases examining differences in hepatitis C infection trends among people who inject drugs across cities in North America, Australia, and the Netherlands. Barton notes, “Authors of the study … say the differences in incidence reflect differences in policies to reduce the harm of injecting drug use…” (5/8).